AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma.
- DOI
- 10.1038/s41420-026-03057-3
- Published
- 2026 Mar 23
- Container
- Cell death discovery
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41420-026-03057-3,
title = {AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma.},
author = {Berra C and Leclair HM and Sebillot A and Schausi D and Guillo J and Baietti MF and Leucci E and Galibert MD and Corre S},
year = {2026},
journal = {Cell death discovery},
doi = {10.1038/s41420-026-03057-3},
url = {https://doi.org/10.1038/s41420-026-03057-3}
}RIS
TY - JOUR TI - AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma. AU - Berra C AU - Leclair HM AU - Sebillot A AU - Schausi D AU - Guillo J AU - Baietti MF AU - Leucci E AU - Galibert MD AU - Corre S PY - 2026 JO - Cell death discovery DO - 10.1038/s41420-026-03057-3 UR - https://doi.org/10.1038/s41420-026-03057-3 ER -
APA
C, B., HM, L., A, S., D, S., J, G., MF, B., E, L., MD, G., & S, C. (2026). AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma.. Cell death discovery. https://doi.org/10.1038/s41420-026-03057-3
Source records
- pubmed · retrieved 2026-09-25T18:36:55.846Z